Literature DB >> 15150404

The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradation.

Markus Welcker1, Amir Orian, Jianping Jin, Jonathan E Grim, Jonathan A Grim, J Wade Harper, Robert N Eisenman, Bruce E Clurman.   

Abstract

Myc proteins regulate cell growth and division and are implicated in a wide range of human cancers. We show here that Fbw7, a component of the SCF(Fbw7) ubiquitin ligase and a tumor suppressor, promotes proteasome-dependent c-Myc turnover in vivo and c-Myc ubiquitination in vitro. Phosphorylation of c-Myc on threonine-58 (T58) by glycogen synthase kinase 3 regulates the binding of Fbw7 to c-Myc as well as Fbw7-mediated c-Myc degradation and ubiquitination. T58 is the most frequent site of c-myc mutations in lymphoma cells, and our findings suggest that c-Myc activation is one of the key oncogenic consequences of Fbw7 loss in cancer. Because Fbw7 mediates the degradation of cyclin E, Notch, and c-Jun, as well as c-Myc, the loss of Fbw7 is likely to elicit profound effects on cell proliferation during tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15150404      PMCID: PMC428477          DOI: 10.1073/pnas.0402770101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  43 in total

1.  Transforming ability of Gag-Myc fusion proteins correlates with Gag-Myc protein stability and transcriptional repression.

Authors:  W Law; M L Linial
Journal:  Oncogene       Date:  2001-03-01       Impact factor: 9.867

2.  A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells.

Authors:  Elizabeth Yeh; Melissa Cunningham; Hugh Arnold; Dawn Chasse; Teresa Monteith; Giovanni Ivaldi; William C Hahn; P Todd Stukenberg; Shirish Shenolikar; Takafumi Uchida; Christopher M Counter; Joseph R Nevins; Anthony R Means; Rosalie Sears
Journal:  Nat Cell Biol       Date:  2004-03-14       Impact factor: 28.824

3.  Degradation of nuclear oncoproteins by the ubiquitin system in vitro.

Authors:  A Ciechanover; J A DiGiuseppe; B Bercovich; A Orian; J D Richter; A L Schwartz; G M Brodeur
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-01       Impact factor: 11.205

4.  Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line.

Authors:  J P Morgenstern; H Land
Journal:  Nucleic Acids Res       Date:  1990-06-25       Impact factor: 16.971

5.  Proteins encoded by the human c-myc oncogene: differential expression in neoplastic cells.

Authors:  S R Hann; R N Eisenman
Journal:  Mol Cell Biol       Date:  1984-11       Impact factor: 4.272

6.  Role of the F-box protein Skp2 in lymphomagenesis.

Authors:  E Latres; R Chiarle; B A Schulman; N P Pavletich; A Pellicer; G Inghirami; M Pagano
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-20       Impact factor: 11.205

7.  Clustered mutations in the second exon of the MYC gene in sporadic Burkitt's lymphoma.

Authors:  T Yano; C A Sander; H M Clark; M V Dolezal; E S Jaffe; M Raffeld
Journal:  Oncogene       Date:  1993-10       Impact factor: 9.867

8.  Point mutations in the c-Myc transactivation domain are common in Burkitt's lymphoma and mouse plasmacytomas.

Authors:  K Bhatia; K Huppi; G Spangler; D Siwarski; R Iyer; I Magrath
Journal:  Nat Genet       Date:  1993-09       Impact factor: 38.330

9.  Defective cardiovascular development and elevated cyclin E and Notch proteins in mice lacking the Fbw7 F-box protein.

Authors:  Michael T Tetzlaff; Wei Yu; Mamie Li; Pumin Zhang; Milton Finegold; Kathleen Mahon; J Wade Harper; Robert J Schwartz; Stephen J Elledge
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-06       Impact factor: 11.205

10.  Phosphorylation sites mapping in the N-terminal domain of c-myc modulate its transforming potential.

Authors:  M Henriksson; A Bakardjiev; G Klein; B Lüscher
Journal:  Oncogene       Date:  1993-12       Impact factor: 9.867

View more
  426 in total

1.  Nucleophosmin is essential for c-Myc nucleolar localization and c-Myc-mediated rDNA transcription.

Authors:  Z Li; S R Hann
Journal:  Oncogene       Date:  2012-06-04       Impact factor: 9.867

2.  GSK-3β regulates cell growth, migration, and angiogenesis via Fbw7 and USP28-dependent degradation of HIF-1α.

Authors:  Daniela Flügel; Agnes Görlach; Thomas Kietzmann
Journal:  Blood       Date:  2011-12-05       Impact factor: 22.113

3.  Myc degradation: dancing with ubiquitin ligases.

Authors:  Bruno Amati
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-08       Impact factor: 11.205

4.  Ubiquitylation of the amino terminus of Myc by SCF(β-TrCP) antagonizes SCF(Fbw7)-mediated turnover.

Authors:  Nikita Popov; Christina Schülein; Laura A Jaenicke; Martin Eilers
Journal:  Nat Cell Biol       Date:  2010-09-19       Impact factor: 28.824

5.  The ubiquitin ligase Fbxw7 controls adipocyte differentiation by targeting C/EBPalpha for degradation.

Authors:  Maria T Bengoechea-Alonso; Johan Ericsson
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-01       Impact factor: 11.205

6.  Substrate phosphorylation and feedback regulation in JFK-promoted p53 destabilization.

Authors:  Luyang Sun; Lei Shi; Feng Wang; Peiwei Huangyang; Wenzhe Si; Jie Yang; Zhi Yao; Yongfeng Shang
Journal:  J Biol Chem       Date:  2010-12-02       Impact factor: 5.157

Review 7.  The various roles of ubiquitin in Wnt pathway regulation.

Authors:  Daniele V F Tauriello; Madelon M Maurice
Journal:  Cell Cycle       Date:  2010-09-25       Impact factor: 4.534

8.  Metabolic Reprogramming by Dual AKT/ERK Inhibition through Imipridones Elicits Unique Vulnerabilities in Glioblastoma.

Authors:  Chiaki T Ishida; Yiru Zhang; Elena Bianchetti; Chang Shu; Trang T T Nguyen; Giulio Kleiner; Maria J Sanchez-Quintero; Catarina M Quinzii; Mike-Andrew Westhoff; Georg Karpel-Massler; Varun V Prabhu; Joshua E Allen; Markus D Siegelin
Journal:  Clin Cancer Res       Date:  2018-07-23       Impact factor: 12.531

9.  IL-6-induced stimulation of c-myc translation in multiple myeloma cells is mediated by myc internal ribosome entry site function and the RNA-binding protein, hnRNP A1.

Authors:  Yijiang Shi; Patrick J Frost; Bao Q Hoang; Angelica Benavides; Sanjai Sharma; Joseph F Gera; Alan K Lichtenstein
Journal:  Cancer Res       Date:  2008-12-15       Impact factor: 12.701

10.  The c-MYC oncoprotein is a substrate of the acetyltransferases hGCN5/PCAF and TIP60.

Authors:  Jagruti H Patel; Yanping Du; Penny G Ard; Charles Phillips; Beth Carella; Chi-Ju Chen; Carrie Rakowski; Chandrima Chatterjee; Paul M Lieberman; William S Lane; Gerd A Blobel; Steven B McMahon
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.